{"certainAgreement":{"otherDetails":"The sponsor can review/embargo results communications prior to public release for a period that is \\>60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Two (2) subjects were enrolled in the safety lead-in part of the study. The study closed early due to slow accrual."},"pointOfContact":{"email":"charles.davis2@scri-innovations.com","organization":"Sarah Cannon Development Innovations","phone":"615-524-4341","title":"Charles H. Davis, RAC"}}